Vitro Diagnostics Announces Application of its Stem Cell Technology to Cancer Research & Treatment

GOLDEN, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced advances in its adult stem cell research indicating application of its technology and stem cell lines to cancer research and treatment. Cancer stem cells may generate solid tumors in various forms of cancer including those with poor prognosis including malignancies of the pancreas, lung and brain. Cancer stem cells may also be resistant to chemotherapy and radiation causing recurrences and metastasis of cancer following standard therapy. Additional research shows that other stem cells, including a type of adult stem cell known as mesenchymal stem cells (MSC) that Vitro is presently developing, migrate to cancer stem cells and may be used to carry toxic agents to selectively eradicate cancer stem cells thereby providing novel cellular therapy specifically targeted to cancer-causing cells.